ACME DRY ICE AND ICE, INC.

ACME DRY ICE AND ICE, INC. specializes in the manufacturing and delivery of dry ice for mission-critical applications within federal healthcare and laboratory environments. Leveraging industrial gas manufacturing expertise under NAICS 325120, the company provides consistent, high-purity solid carbon dioxide for temperature-sensitive transport, medical specimen preservation, and cold chain logistics. Their operational focus centers on just-in-time delivery of dry ice in controlled quantities, ensuring compliance with thermal stability requirements for biological samples, pharmaceuticals, and medical devices. Technical proficiency includes cryogenic handling, insulated container logistics, and adherence to federal cold chain standards, with an emphasis on reliability and contamination-free delivery protocols. The contractor maintains a sustained, recurring relationship with the Department of Veterans Affairs, delivering dry ice services across VA medical centers, research laboratories, and blood bank operations. Their work supports VA’s healthcare infrastructure by enabling safe storage and transport of vaccines, tissue samples, and temperature-sensitive medical supplies, indicating deep integration into VA’s supply chain for perishable biomedical materials. Operating under the industrial gas manufacturing classification, ACME DRY ICE AND ICE, INC. occupies a niche within the federal life sciences supply market, serving entities requiring precision cryogenic support. Their market positioning is defined by specialized delivery of solid carbon dioxide rather than bulk gas distribution, distinguishing them from broader industrial gas suppliers. As a small business structured as a 2L entity based in Cambridge, Massachusetts, the company operates with a focused, regionally anchored footprint. While no federal certifications are listed, their consistent performance with the VA underscores a proven track record in meeting stringent government service requirements. Their geographic proximity to major medical and research institutions enhances responsiveness and operational agility within the federal healthcare sector.